Epoetin is a tempting sideline for dialysis units in the USBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7599.872-c (Published 26 April 2007) Cite this as: BMJ 2007;334:872
Patients with chronic kidney disease often need synthetic erythropoietin to prevent anaemia and keep transfusions to a minimum. But evidence is emerging of systematic overtreatment by some dialysis facilities in the United States. The problem seems to be linked to a perverse reimbursement arrangement …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial